40% of diseases linked to lifestyle, says MEP

19 October 2008

Better prevention and closing the disparities between countries in terms of health care are just issues raised in a health action plan debated recently by Members of the European Parliament. Slovenian MEP and cancer survivor Alojz Peterle drafted Parliament's response to the proposed Commission action plan over the next five years.

The report highlights adverse health trends, especially "lifestyle diseases," the rising cost of medicines and variations in life expectancy (nine years women/13 years men). It also says that prevention-only treatment amounts to 3% of health spending in the European Union and that 40% of diseases are linked to lifestyle.

Speaking in the debate, Mr Peterle said that the EU must make "a strategic shift towards disease prevention." Swedish Socialist Asa Westlund highlighted the "inequalities within member states." This point was taken up by Cypriot Liberal Member Marios Matsakis who spoke of the "shameful differences between richer and poorer countries."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight